Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients.

Wei, Hongtao; Yu, Xiaotong; Xue, Xiaowei; Liu, Hui; Wang, Menglong; Li, Yingying; Wang, Xuejiang; Ding, Huiguo

Wei, Hongtao; Yu, Xiaotong; Xue, Xiaowei; Liu, Hui; Wang, Menglong; Li, Yingying; Wang, Xuejiang; Ding, Huiguo.

Afiliación

Wei H; Department of Emergency, Beijing Friendship Hospital, Capital Medical University, Beijing 100069, P.R. China.
Yu X; Department of Gastroenterology and Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, P.R. China.
Xue X; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, P.R. China.
Liu H; Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, P.R. China.
Wang M; Department of Gastroenterology and Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, P.R. China.
Li Y; Department of Gastroenterology and Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, P.R. China.
Wang X; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, P.R. China.
Ding H; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, P.R. China.

Oncol Lett ; 14(3): 2749-2756, 2017 Sep.

Article en En | MEDLINE | ID: mdl-28927036

Palabras clave

hepatocellular carcinoma; motility; prognosis; urotensin II receptor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncol Lett Año: 2017 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google